Skip to main content

Advertisement

Log in

Astragalin alleviates cognitive deficits and neuronal damage in SAMP8 mice through upregulating estrogen receptor expression

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

A Correction to this article was published on 02 November 2022

This article has been updated

Abstract

Senile plaques composed of β-amyloid protein (Aβ) and neurofibrillary tangles (NFTs) composed of intracellular hyper-phosphorylated tau are major causes of cognitive impairment and neuronal damage in Alzheimer disease (AD). Astragalin (AST), a naturally-occurring flavonoid compound, was reported to have neuroprotective effects in the brain, but its effects in AD remain unknown. Herein, the learning and memory deficits were alleviated and neuronal damage in the hippocampus were inhibited after the senescence-accelerated mouse prone 8 (SAMP8) mouse were given AST (5 mg/kg or 10 mg/kg) daily by gavage for 2 months. Furthermore, AST reduced Aβ1−40 and Aβ1−42 deposition, decreased β-carboxyl-terminal fragment (β-CTF) protein level and tau hyper-phosphorylation, but increased α-CTF protein level and glycogen synthase kinase-3beta (GSK-3β) phosphorylation in hippocampus of SAMP8 mice. Meanwhile, the effects of AST on AD were also explored in vitro by treating primary neurons with amyloid-β1–42 oligomers (Aβ1−42O). Consistently, AST also alleviated amyloid-β1–42 oligomers (Aβ1−42O)-induced neuronal damage, amyloid plaques, and tau phosphorylation in vitro model. Of note, estrogen receptor (ER)α and ERβ expression in the hippocampus of SAMP8 mice and Aβ1−42O-treated neurons was significantly decreased but their levels were increased by AST. Moreover, in vivo and in vitro experiments revealed that ER antagonist, Fulvestrant, reversed the effects caused by AST. Altogether, our investigation indicates that AST may ameliorate cognitive deficits and AD-type pathologies in SAMP8 mice and Aβ1−42O-treated neurons through upregulating ERα and ERβ expression. Our findings indicate the value of AST as a potential reagent for AD treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data Availability

The data will be made available from the corresponding author on reasonable request.

Change history

References

Download references

Funding

This research was supported by grants from the Surface Project of National Natural Science Foundation of China (82074288), the Youth Fund Project of National Natural Science Foundation of China (81403288), the Science Foundation for Youths of Heilongjiang Province (QC2015102), the Postdoctoral Science Foundation of China (2016M591565), the Project for Young Reserve Talents of Harbin Science and Technology Bureau (2016RAQXJ202) and the Postdoctoral Foundation of Heilongjiang Province (LBH-Z15207).

Author information

Authors and Affiliations

Authors

Contributions

Hong Liu and Jing Yang contributed to the study conception, design, and writing of the manuscript. Material preparation, data collection, and analysis were performed by Lili Zhong, Qiaomei Dai, and Yuwei Zhang. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Jing Yang.

Ethics declarations

Competing interests

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, H., Zhong, L., Dai, Q. et al. Astragalin alleviates cognitive deficits and neuronal damage in SAMP8 mice through upregulating estrogen receptor expression. Metab Brain Dis 37, 3033–3046 (2022). https://doi.org/10.1007/s11011-022-01045-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-022-01045-x

Keywords

Navigation